Who is sponsoring NCT00666055?

NCT00666055 is sponsored by Kristine Patterson, MD.

What condition does NCT00666055 study?

NCT00666055 studies HIV Infections.

What drugs are being tested in NCT00666055?

Interventions: ARV regimen chosen by treating physician.

What is the status of NCT00666055?

NCT00666055 is currently COMPLETED.

Last reviewed 2012-09-18 · How we verify

CID 0708 - Sex, Aging and Antiretroviral Pharmacokinetics

NCT00666055 COMPLETED

The purpose of this research study is to learn about levels of antiretroviral drug levels and response to HIV virus in the genital tract of women who are post-menopausal. The investigators in this study think that the levels of hormones post-menopausal HIV-infected women may have in their bodies may affect the levels of antiretroviral drug, and therefore affect how much HIV virus they have in their bodies. Since women who have already gone through menopause have different levels of hormones, such as estrogen, than women who are pre-menopausal, the investigators would like to check the levels of antiretroviral drugs in their blood, their genital secretions, and their genital tissue.

Details

Lead sponsor	Kristine Patterson, MD
Status	COMPLETED
Enrolment	11
Start date	2008-03
Completion	2012-05

Conditions

HIV Infections

Interventions

ARV regimen chosen by treating physician

Primary outcomes

To measure and compare steady state blood plasma pharmacokinetics of antiretroviral therapies in post- and pre-menopausal HIV-infected women. — 6 months

Countries

United States